Recombinant Human TGF-ERR1 (HEK293 derived) and 4 more items

Quartzy was awarded contract A207_PO-0434396-V3 by the University of Virginia on June 13, 2026, with a cumulative contract value of $1,786.60. The contract encompasses the procurement of specialized laboratory and research materials to support the university's scientific operations. The primary deliverables include recombinant proteins such as Human TGF-ERR1 derived from human embryonic kidney cells and Recombinant Murine Granulocyte-Macrophage Colony-Stimulating Factor, as well as immunological reagents including Tom20 Mouse antibodies (Clone 29, manufactured by Becton Dickinson).

The contract additionally covers essential laboratory infrastructure and consumables, specifically replacement in-chamber High-Efficiency Particulate Air filters designed for Heracell and Forma incubation systems, and DNA purification columns. Line items indicate quantities ranging from 221 to 662 units across the various product categories, with uniform unit pricing. All items are designated for delivery to the University of Virginia as the purchasing entity. The contract represents a purchase order within the Commonwealth of Virginia's procurement framework, with performance expected at the university's facilities.